EU To Develop Uniform Approach To COVID-19 Vaccination Certificates
The European Commission (EC) believes that a unified approach to pharmacovigilance and to reliable and verifiable vaccination certificates in the EU can strengthen the success of vaccination programmes in member states and citizens’ confidence in the process.
The EU Heads of State and Government at their summit on 10 December tasked the European Commission to « develop a coordinated approach to vaccination certificates », the European Council said in a final document.
« Proof of vaccination should be available from the moment vaccination starts. Vaccination certificates can be useful, for example in the context of travel, showing that a person has been vaccinated and therefore may not need to be tested and quarantined on arrival in another country, » the European Commission’s extensive background paper noted.
The EC briefing note also notes that relevant WHO experience will be taken into account and complemented in the process.
Earlier, a European Commission spokesperson told that the European Union was exploring all ways to return to normal life while protecting citizens against COVID-19 through various methods, including the use of vaccination certificates.
The European Medicines Agency (EMA) recommended on December 21 that a vaccine developed by Pfizer and BioNTech against the COVID-19 coronavirus be approved for use in the EU. On the same day, the European Commission gave its approval for the emergency use of the vaccine.
« Vaccination can therefore start simultaneously in the European Union on 27, 28 and 29 December. This is a very good way to end this difficult year and finally start turning the pages about COVID-19, » said European Commission President Ursula von der Leyen after the EC’s decision to release the vaccine to the EU market.